CORRESP 1 filename1.htm

 

Nephros, Inc.

380 Lackawanna Place

South Orange, NJ 07079

(201) 343-5202

 

December 4, 2019

 

Via Edgar Transmission

 

Ms. Irene Paik

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

Washington, D.C. 20549

 

 

Re:

Nephros, Inc. (the “Company”)

Registration Statement on Form S-3

File No. 333-234528

 

Dear Ms. Paik:

 

On behalf of the Company, the undersigned respectfully requests that the above-referenced registration statement be declared effective at 4:00 p.m., Washington, D.C. time, on December 6, 2019, or as soon thereafter as is practicable.

 

  Sincerely,
   
  Nephros, Inc.
     
  By: /s/ Andrew Astor
    Andrew Astor
    Chief Financial Officer &
    Chief Operating Officer